According to early data from laboratory studies, the Covid-19 treatment appears to be effective against the omicron variant of coronaviruses.
The U.K. approved sotrovimab.
The images are from the same company.
The study on hamsters used to model human respiratory diseases suggests that sotrovimab is still effective against the omicron variant.
The activity of Sotrovimab against the new variant is being tested to make sure it is still effective against all omicron mutations.
An update will be provided by the end of the year.
The U.K. approved sotrovimab, marketed as Xevudy, for use in patients with mild-to-moderate Covid-19 at risk of severe illness.
A single dose of the treatment reduced the risk of hospitalisation and death in high-risk adults with Covid-19 infections, according to a clinical trial.
The agency will work with the two companies to establish the effectiveness of the treatment.
Continue watching after the ad Visit Advertiser website.
George Scangos said that sotrovimab was designed to target a part of the virus that is less likely to change. Scangos said that future coronaviruses would be inevitable and that he was confident that the treatment would work against the full combination of omicron genes.
The World Health Organization designated omicron, or B. 1.1.529, a variant of concern last week after researchers in South Africa sounded the alarm over a highly-spliced form of the virus. The high number of mutations could make the strain more transmissible and make our weapons against the virus less effective. Major producers are investigating the variant of the vaccine because of its diminished efficacy. Pfizer, BioNTech and Moderna are working on new shots. The treatment for Covid-19 was less effective against omicron than initially thought, according to Regeneron.
What to watch for.
The treatment will be deployed to patients by the U.K. government and National Health Service. This will happen in due course according to the MHRA. The treatment was approved for use in people who weigh more than 40 kilograms and have mild-to-moderate Covid-19, as well as older people who have diabetes or heart disease.
The company is testing its therapy against the Omicron variant.
The UK approves another treatment for Covid.
Covid-19 is not done with us, the WHO leader wants vaccine equity over boosters, because of the high risk of Omicron spreading internationally.
The first cases of Omicron variant were found in North America.
Coverage and live updates on the coronaviruses.
